Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Símbolo desconocido
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
09/07/202400:00Business WireCARMAT accélère la dynamique de ses ventes et réitère sa confiance dans ses perspectives de développementEU:ALCARCarmat
09/07/202400:00Business WireVictory Capital and Amundi Execute Definitive Agreement to Become Strategic PartnersNASDAQ:VCTRVictory Capital Holdings Inc
09/07/202400:00GlobeNewswire Inc.Vivoryon Therapeutics N.V. to Host R&D Update Call on July 18, 2024 Focused on Progress in Kidney DiseaseVVY
09/07/202400:00Business WireCyemptive Technologies annonce un partenariat de liaison avec le Partnership for Cyber Security Innovation basé aux Pays-Bas
09/07/202400:00Business WireCARMAT accelerates its sales momentum and reiterates its confidence in its development outlookEU:ALCARCarmat
09/07/202400:00PR Newswire (US)DataShapes AI to Participate in Cyber Quest 2024
08/07/202423:58Alliance NewsAlliance NewsTOP NEWS: Cooler weather pegs back UK retail sales in June
08/07/202423:44Alliance NewsAlliance NewsGLOBAL BRIEFING: Stocks mixed but dollar firms, Biden doubles down
08/07/202423:39PR Newswire (US)NeuroX Selected by Centers for Medicare & Medicaid Services to Test Medicare Dementia Care Model
08/07/202423:37CointelegraphDubai Customs launches blockchain platform amid smart city effortCOIN:BTCUSDBitcoin
08/07/202423:25Crypto BriefingDigitalX set to launch Bitcoin ETF on Australia’s top exchange ASX: BloombergCOIN:BTCUSDBitcoin
08/07/202423:01PR Newswire (US)Can M&A Bounce Back in 2024? Second Half of 2024 Points to a Mixed Recovery for M&A
08/07/202423:01PR Newswire (US)Boston Consulting Group Joins Greentown Labs as a Terawatt Partner
08/07/202423:01PR Newswire (US)Interius BioTherapeutics Receives HREC Approval and CTN Clearance from the TGA to Commence a Phase 1 Clinical Trial for Its First-in-Class In Vivo CAR Therapeutic for B Cell Malignancies
08/07/202423:00NEWSBTCBitcoin MVRV Ratio At Make-Or-Break Test: Will Support Hold?COIN:BTCUSDBitcoin
08/07/202423:00PR Newswire (US)Summer becomes a thrilling adventure for a teenage boy after planting an unusual rock in his backyard that grows into a towering mountain
08/07/202423:00PR Newswire (US)THINKFREE Launches Beta Version of Global Corporate AI Search Service Refinder AI
08/07/202423:00PR Newswire (US)Peter Durbin explores the mysteries of the End Times and beyond in 'What`s Really Going On?'
08/07/202423:00PR Newswire (US)Universal Robots celebrates milestone with over 500 innovative products in its ever-expanding ecosystem
08/07/202423:00PR Newswire (US)Fluree Named a 2024 Gartner Cool Vendor in Data Management
08/07/202422:52PR Newswire (Canada)TSX Venture Exchange Stock Maintenance Bulletins
08/07/202422:48NEWSBTCEthereum Targets $3,320: Bulls Eye Recovery with Base FormationCOIN:BTCUSDBitcoin
08/07/202422:40The Daily HodlCryptocurrency and Blockchain – The Duo Transforming FinanceCOIN:FETUSDFetch
08/07/202422:30Business WireSAMAJ calls for collective action against sexual violence in South Asia
08/07/202422:09Crypto BriefingBlackRock’s BUIDL fund becomes first $500M tokenized fundCOIN:BTCUSDBitcoin
08/07/202422:00NEWSBTCLegendary Trader Peter Brandt Says Bitcoin Could Crash To $44,000, Here’s WhyCOIN:SHIBUSDSHIBA INU
08/07/202421:56PR Newswire (US)STEM Director Named America's Favorite Teacher 2024: Colossal Raises Over $2.7 Million Benefiting Teach For America
08/07/202421:54PR Newswire (US)UNLIMEAT Introduces Its K-Vegan Products at Sprouts Farmers Market
08/07/202421:51NEWSBTCBitcoin Price Stabilizes After Losses: Can Bulls Overcome Resistance for a Recovery?COIN:BTCUSDBitcoin
08/07/202421:45CointelegraphEthereum to launch first $2M protocol-wide ‘Attackathon’COIN:ETHUSDEthereum